Acquire the license to the best health content in the world
Contact Us

Clinical Trials Update: March 25, 2008

Gastroesophageal Reflux Disease (GERD) Multiple Sclerosis Healthy Patient Studies

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Gastroesophageal Reflux Disease (GERD)

If you are 18 to 65, have nighttime heartburn with GERD-associated sleep disturbance, have been diagnosed with esophageal erosions for at least six months, and are willing to have screening procedures that may include endoscopy, you may qualify for this study.

The research site is in Nashville, Tenn.

More information

Please see http://www.centerwatch.com/patient/studies/cat70.html.

-----

Multiple Sclerosis

If you have relapsing MS, have a screening EDSS score below 6.0, have had at least one clinical relapse in the past 12 months, and have failed beta-interferon treatment, you may qualify for this study.

The research site is in Washington, D.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat102.html.

-----

Healthy Patient Studies

If you are a healthy male or female aged 18 to 40, you may qualify for this outpatient study. No overnight stays are required.

The research site is in Daytona Beach, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/phasei.html.

-----

Copyright 2008 Thomson CenterWatch. All rights reserved.

Consumer News